FDA Approves Another Amazing And Costly Cancer-Killing Gene Therapy

The Food and Drug Administration just approved Yescarta, a treatment that genetically modifies a patient ' s own white cells to battle lymphoma. The price? $373,000.

Source: Forbes.com Healthcare News - October 18, 2017 Category: Pharmaceuticals Authors: Matthew Herper, Forbes Staff Tags: NASDAQ:KITE NASDAQ:GILD NYSE:NVS Source Type: news